Host-Directed Therapies for Tuberculosis
TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entir...
Saved in:
| Sonstige: | |
|---|---|
| Year of Publication: | 2020 |
| Language: | English |
| Physical Description: | 1 electronic resource (120 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| id |
993546600404498 |
|---|---|
| ctrlnum |
(CKB)5400000000045377 (oapen)https://directory.doabooks.org/handle/20.500.12854/69310 (EXLCZ)995400000000045377 |
| collection |
bib_alma |
| record_format |
marc |
| spelling |
Venketaraman, Vishwanath edt Host-Directed Therapies for Tuberculosis Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (120 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB. English Research & information: general bicssc Biology, life sciences bicssc Mycobacterium tuberculosis host-directed therapies immune responses tuberculosis lung cancer misdiagnosis invasive procedure revising antiplatelet aspirin immunomodulation survival Taiwan latent infection pulmonary rabbit iron supplementation pathology immune response gene expression Perls’ stain autophagy M. tb BCG vaccination immune exhaustion glutathione cytokines granulomas type 2 diabetes co-morbidities co-infections inflammation redox imbalance antioxidants 3-03943-501-9 3-03943-502-7 Venketaraman, Vishwanath oth |
| language |
English |
| format |
eBook |
| author2 |
Venketaraman, Vishwanath |
| author_facet |
Venketaraman, Vishwanath |
| author2_variant |
v v vv |
| author2_role |
Sonstige |
| title |
Host-Directed Therapies for Tuberculosis |
| spellingShingle |
Host-Directed Therapies for Tuberculosis |
| title_full |
Host-Directed Therapies for Tuberculosis |
| title_fullStr |
Host-Directed Therapies for Tuberculosis |
| title_full_unstemmed |
Host-Directed Therapies for Tuberculosis |
| title_auth |
Host-Directed Therapies for Tuberculosis |
| title_new |
Host-Directed Therapies for Tuberculosis |
| title_sort |
host-directed therapies for tuberculosis |
| publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
| publishDate |
2020 |
| physical |
1 electronic resource (120 p.) |
| isbn |
3-03943-501-9 3-03943-502-7 |
| illustrated |
Not Illustrated |
| work_keys_str_mv |
AT venketaramanvishwanath hostdirectedtherapiesfortuberculosis |
| status_str |
n |
| ids_txt_mv |
(CKB)5400000000045377 (oapen)https://directory.doabooks.org/handle/20.500.12854/69310 (EXLCZ)995400000000045377 |
| carrierType_str_mv |
cr |
| is_hierarchy_title |
Host-Directed Therapies for Tuberculosis |
| author2_original_writing_str_mv |
noLinkedField |
| _version_ |
1796652002288074753 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02919nam-a2200709z--4500</leader><controlfield tag="001">993546600404498</controlfield><controlfield tag="005">20231214133133.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000045377</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/69310</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000045377</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Venketaraman, Vishwanath</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Host-Directed Therapies for Tuberculosis</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (120 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">TB is considered as one of the oldest documented infectious diseases in the world and is believed to be the leading cause of mortality due to a single infectious agent. Mtb, the causative agent responsible for TB, continues to afflict millions of people worldwide. Furthermore, one-third of the entire world's population has latent TB. Consequently, there has been a worldwide effort to eradicate and limit the spread of Mtb through the use of antibiotics. However, management of TB is becoming more challenging with the emergence of drug-resistant and multi-drug resistant strains of Mtb. Furthermore, when administered, many of the anti-TB drugs commonly present severe complications and side effects. Novel approaches to enhance the host immune responses to completely eradicate Mtb infection are urgently needed. This Special Issue will therefore cover most recent advances in the area of host-directed therapies for TB.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Research & information: general</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Biology, life sciences</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mycobacterium tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">host-directed therapies</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune responses</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tuberculosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">lung cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">misdiagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasive procedure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">revising</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antiplatelet</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">aspirin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunomodulation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Taiwan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">latent infection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pulmonary</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">rabbit</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron supplementation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pathology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune response</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">gene expression</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Perls’ stain</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">M. tb</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BCG vaccination</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immune exhaustion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">glutathione</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cytokines</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">granulomas</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">type 2 diabetes</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">co-morbidities</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">co-infections</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">inflammation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">redox imbalance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">antioxidants</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-501-9</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-502-7</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Venketaraman, Vishwanath</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:43:40 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338242710004498&Force_direct=true</subfield><subfield code="Z">5338242710004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338242710004498</subfield></datafield></record></collection> |